Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Alopecia areata is linked to thyroid autoimmunity but not type 1 diabetes.

Hair loss in women not always linked to increased oil production; other factors may be involved.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Scientists developed a method to grow human fetal skin and digits in a lab for 3-4 weeks, which could help study skin features and understand genetic interactions in tissue formation.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Topical spironolactone cream doesn't cause hormone-related side effects in the body.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

Hirsutism, excessive hair growth in women, is often caused by PCOS and can be managed with medication and personalized treatment plans.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

Hormone imbalances from the pituitary, thyroid, and adrenal glands can cause infertility, but treating these disorders can improve fertility.

The patient likely has Chrousos syndrome, a rare condition causing insensitivity to glucocorticoids, requiring high-dose dexamethasone treatment.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Human hair follicle organ culture is a useful model for hair research with potential for studying hair biology and testing treatments.

Skin problems in older people can indicate hormonal diseases, nutritional deficiencies, or conditions like diabetes, menopause, and HIV.

Organs like hair follicles can renew themselves in complex ways, adapting to different needs and environments.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Hormone imbalances from endocrine diseases can cause various skin conditions that help diagnose and treat these diseases early.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

Removing Sprouty genes in mice causes various hormone-related issues but does not increase cancer risk by one year of age.

Growth factors are crucial for hair development and could help treat hair diseases.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Diabetes can lead to blindness and skin problems, and managing blood sugar and blood pressure is crucial to prevent these complications.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.